Table 1.
Neurologic Manifestations of Sarcoidosis
| Zajicek et al. [20] N=68 |
Joseph and Scolding [9] N=30 |
Pawate et al. [11] N=54 |
Delaney, et al. [5] N = 23 |
Stern, et al. [4] N = 33 |
Chapelon, et al. [6] N = 35 |
Oksanen [10] N = 50 |
Lower, et al. [3] N = 71 |
Wiederholt, Siekert [7] N = 28 |
|
|---|---|---|---|---|---|---|---|---|---|
| Cranial neuropathy % (N) | 34 (23) | 28 (8) | 23 (12) | 48 (11) | 73 (24) | 34 (12) | 42 (21) | 70 (50) | 64 (18) |
| Optic neuropathy | 38 (26) | 37 (11) | 35 (19) | 30 (7) | 12 (4) | 3 (1) | 10 (5) | 10 (7) | 21 (6) |
| Endocrine/hypothalamic dysfunction | 3 (2) | 17 (5) | 2 (1) | 26 (6) | 15 (5) | 11 (4) | 10 (5) | 8 (6) | 25 (7) |
| Other intracranial mass | -- | -- | -- | 35 (8) | 0 (0) | -- | |||
| Seizures | -- | 10 (3) | 17 (9) | 22 (5) | 0 (0) | 14 (5) | 18 (9) | 7 (5) | 18 (5) |
| Meningitis | 12 (8) | 22 (7) | -- | 26 (6) | 18 (6) | 40 (14) | 8 (4) | 40 (28) | -- |
| Myelopathy | 28 (19) | 15 (5) | 19 (10) | 9 (2) | 6 (2) | 0 (0) | 10 (5) | -- | 4 (1) |
| Peripheral Neuropathy | -- | -- | 2 (1) | 4 (1) | 6 (2) | 40 (14) | 18 (9) | 4 (3) | 14 (4) |
| Myopathy | -- | -- | -- | 9 (2) | 12 (4) | 26 (6) | 10 (5) | -- | 7 (2) |